Search results
KeViRx, Inc. Awarded $1.99 Million
Digital Journal· 2 hours agoDepartment of Defense grant will advance small molecule technology for acute lung injuryCHARLOTTESVILLE, VA / ACCESSWIRE / June 11, 2024 / KeViRx, Inc., an innovative, early ...
Netflix Inc: An Exploration into Its Intrinsic Value
GuruFocus.com via Yahoo Finance· 4 hours agoAs of 2024-06-11, Netflix Inc's intrinsic value as calculated by the Discounted Earnings model is $450...overvalued. The model The GuruFocus DCF...
BM Technologies, Inc. (BMTX) Just Flashed Golden Cross Signal: Do You Buy?
Zacks via Yahoo Finance· 2 hours agoThe third stage is when a stock continues the upward momentum to higher prices. A golden cross is...
Amazon.com, Inc.'s (NASDAQ:AMZN) Intrinsic Value Is Potentially 68% Above Its Share Price
Simply Wall St. via Yahoo Finance· 4 hours agoThreat Revenue is forecast to grow slower than 20% per year. Next Steps: Although the valuation of a...
Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal
Zacks via Yahoo Finance· 2 hours agoData from a late-stage study shows that Moderna's (MRNA) experimental COVID-19-influenza combination...
Decoding Autodesk Inc (ADSK): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 11 hours agoTechnological Leadership and Innovation: Autodesk Inc's commitment to innovation is evident in its...
Agenus (NASDAQ:AGEN) Stock Crosses Above 200-Day Moving Average of $12.95
ETF DAILY NEWS· 13 hours agoAgenus Inc. (NASDAQ:AGEN – Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $12.95 and traded ...
BioLargo Manufactures First Cellinity Battery Cells, a Safer Alternative to Lithium-ion
Digital Journal· 3 hours ago(OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech...cells will now be tested and validated for the energy storage and ...
Brokerages Set Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Target Price at $64.86
ETF DAILY NEWS· 13 hours agoArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) has been assigned a consensus recommendation of “Buy” from the seven research firms ...